Chengdu Olymvax Biopharmaceuticals Inc
SSE:688319

Watchlist Manager
Chengdu Olymvax Biopharmaceuticals Inc Logo
Chengdu Olymvax Biopharmaceuticals Inc
SSE:688319
Watchlist
Price: 27.66 CNY 3.83%
Market Cap: 11.2B CNY

Chengdu Olymvax Biopharmaceuticals Inc
EPS (Diluted)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Chengdu Olymvax Biopharmaceuticals Inc
EPS (Diluted) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
Chengdu Olymvax Biopharmaceuticals Inc
SSE:688319
EPS (Diluted)
ÂĄ0
CAGR 3-Years
-44%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
EPS (Diluted)
-ÂĄ3
CAGR 3-Years
21%
CAGR 5-Years
7%
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
EPS (Diluted)
ÂĄ0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Akeso Inc
HKEX:9926
EPS (Diluted)
ÂĄ0
CAGR 3-Years
23%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
EPS (Diluted)
ÂĄ0
CAGR 3-Years
-63%
CAGR 5-Years
-27%
CAGR 10-Years
N/A
S
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
HKEX:6990
EPS (Diluted)
-ÂĄ1
CAGR 3-Years
34%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Chengdu Olymvax Biopharmaceuticals Inc
Glance View

Market Cap
11.2B CNY
Industry
Biotechnology

Chengdu Olymvax Biopharmaceuticals, Inc. engages in the research and development, manufacture, and sale of human-use vaccines. The company is headquartered in Chengdu, Sichuan and currently employs 440 full-time employees. The company went IPO on 2021-06-08. The firm's products mainly include adsorbed tetanus vaccine, Hib conjugate vaccine and tetanus toxoid concentrate stock solution. The firm's main customers are center for disease control and prevention (CDC) customers.

Intrinsic Value
12.1 CNY
Overvaluation 56%
Intrinsic Value
Price

See Also

What is Chengdu Olymvax Biopharmaceuticals Inc's EPS (Diluted)?
EPS (Diluted)
0.1 CNY

Based on the financial report for Dec 31, 2024, Chengdu Olymvax Biopharmaceuticals Inc's EPS (Diluted) amounts to 0.1 CNY.

What is Chengdu Olymvax Biopharmaceuticals Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 3Y
-44%

Over the last year, the EPS (Diluted) growth was 25%. The average annual EPS (Diluted) growth rates for Chengdu Olymvax Biopharmaceuticals Inc have been -44% over the past three years .

Back to Top